{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:21:24Z","timestamp":1793049684779,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bpa.2023.02.003","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T20:17:04Z","timestamp":1679084224000},"page":"157-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Intrathecal drug delivery in the management of chronic pain"],"prefix":"10.1016","volume":"37","author":[{"given":"Jan","family":"Van Zundert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4077","key":"10.1016\/j.bpa.2023.02.003_bib1","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1126\/science.179.4077.1011","article-title":"Opiate receptor: demonstration in nervous tissue","volume":"179","author":"Pert","year":"1973","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bpa.2023.02.003_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00000542-197902000-00013","article-title":"Pain relief by intrathecally applied morphine in man","volume":"50","author":"Wang","year":"1979","journal-title":"Anesthesiology"},{"issue":"8115","key":"10.1016\/j.bpa.2023.02.003_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(79)90947-4","article-title":"Epidural morphine in treatment of pain","volume":"1","author":"Behar","year":"1979","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bpa.2023.02.003_bib4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11916-014-0474-8","article-title":"History and present state of targeted intrathecal drug delivery","volume":"19","author":"Rizvi","year":"2015","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.bpa.2023.02.003_bib5","doi-asserted-by":"crossref","first-page":"900566","DOI":"10.3389\/fpain.2022.900566","article-title":"Intrathecal drug delivery: advances and applications in the management of chronic pain patient","volume":"3","author":"De Andres","year":"2022","journal-title":"Front Pain Res (Lausanne)"},{"issue":"4246","key":"10.1016\/j.bpa.2023.02.003_bib6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.1273597","article-title":"Analgesia mediated by a direct spinal action of narcotics","volume":"192","author":"Yaksh","year":"1976","journal-title":"Science"},{"issue":"5769","key":"10.1016\/j.bpa.2023.02.003_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/286155a0","article-title":"Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo","volume":"286","author":"Yaksh","year":"1980","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bpa.2023.02.003_bib8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.anclin.2007.07.001","article-title":"Intrathecal analgesia","volume":"25","author":"Cohen","year":"2007","journal-title":"Anesthesiol Clin"},{"issue":"3","key":"10.1016\/j.bpa.2023.02.003_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1521-6896(03)00014-4","article-title":"Intrathecal morphine for chronic benign pain","volume":"17","author":"Gerber","year":"2003","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"2","key":"10.1016\/j.bpa.2023.02.003_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.ajp.0000210955.93878.44","article-title":"Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications","volume":"23","author":"Turner","year":"2007","journal-title":"Clin J Pain"},{"issue":"1","key":"10.1016\/j.bpa.2023.02.003_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.nurt.2007.10.070","article-title":"Intrathecal pumps","volume":"5","author":"Belverud","year":"2008","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.bpa.2023.02.003_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00002508-200109000-00004","article-title":"Evaluation of patients for implantable pain modalities: medical and behavioral assessment","volume":"17","author":"Prager","year":"2001","journal-title":"Clin J Pain"},{"issue":"23","key":"10.1016\/j.bpa.2023.02.003_bib13","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2146\/ajhp060204","article-title":"Intrathecal drug therapy for long-term pain management","volume":"64","author":"Ghafoor","year":"2007","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.1016\/j.bpa.2023.02.003_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ner.12538","article-title":"The polyanalgesic consensus conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"issue":"3","key":"10.1016\/j.bpa.2023.02.003_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1526-4637.2007.00355.x","article-title":"Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain","volume":"9","author":"Wallace","year":"2008","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.bpa.2023.02.003_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/ner.12543","article-title":"The polyanalgesic consensus conference (PACC): recommendations for trialing of intrathecal drug delivery infusion therapy","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"issue":"2","key":"10.1016\/j.bpa.2023.02.003_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/ner.12579","article-title":"The polyanalgesic consensus conference (PACC): recommendations for intrathecal drug delivery: guidance for improving safety and mitigating risks","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"issue":"10","key":"10.1016\/j.bpa.2023.02.003_bib18","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/pme.12782","article-title":"Intrathecal therapy: the burden of being positioned as a salvage therapy","volume":"16","author":"Pope","year":"2015","journal-title":"Pain Med"},{"issue":"43","key":"10.1016\/j.bpa.2023.02.003_bib19","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers \u2013 United States, 1999\u20132008","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.bpa.2023.02.003_bib20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/pm\/pny132","article-title":"Intrathecal therapy for chronic pain: a review of morphine and ziconotide as firstline options","volume":"20","author":"Deer","year":"2019","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.bpa.2023.02.003_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00006123-199902000-00026","article-title":"A\u00a0prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain","volume":"44","author":"Anderson","year":"1999","journal-title":"Neurosurgery"},{"issue":"8","key":"10.1016\/j.bpa.2023.02.003_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1067\/S1526-5900(03)00730-2","article-title":"Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain","volume":"4","author":"Rauck","year":"2003","journal-title":"J Pain"},{"issue":"19","key":"10.1016\/j.bpa.2023.02.003_bib23","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","article-title":"Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival","volume":"20","author":"Smith","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bpa.2023.02.003_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.bpa.2023.02.003_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","article-title":"Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Wallace","year":"2006","journal-title":"Neuromodulation"},{"issue":"5","key":"10.1016\/j.bpa.2023.02.003_bib26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"10.1016\/j.bpa.2023.02.003_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pain.2011.10.002","article-title":"Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice","volume":"153","author":"Alicino","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.bpa.2023.02.003_bib28","article-title":"Effectiveness and safety of intrathecal drug delivery systems for the management of cancer pain: a systematic review and meta-analysis","author":"Duarte","year":"2022","journal-title":"Neuromodulation"},{"issue":"4","key":"10.1016\/j.bpa.2023.02.003_bib29","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1213\/ANE.0000000000004276","article-title":"Prospective association of serum opioid levels and clinical outcomes in patients with cancer pain treated with intrathecal opioid therapy","volume":"130","author":"Brogan","year":"2020","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.bpa.2023.02.003_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/AAP.0000000000000251","article-title":"Prospective observational study of patient-controlled intrathecal analgesia: impact on cancer-associated symptoms, breakthrough pain control, and patient satisfaction","volume":"40","author":"Brogan","year":"2015","journal-title":"Reg Anesth Pain Med"},{"issue":"6","key":"10.1016\/j.bpa.2023.02.003_bib31","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1213\/ANE.0000000000002903","article-title":"Intrathecal drug delivery systems for refractory pancreatic cancer pain: observational follow-up study over an 11-year period in a comprehensive cancer center","volume":"126","author":"Carvajal","year":"2018","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.bpa.2023.02.003_bib32","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.21037\/apm-20-1293","article-title":"Effects of family integrated care on refractory cancer-related pain receiving intrathecal morphine pump therapy: a cohort study","volume":"9","author":"Cheng","year":"2020","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.bpa.2023.02.003_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.douler.2011.05.001","article-title":"Refractory cancer pain and intrathecal infusion: experience of three cancer management centers","volume":"12","author":"Dupoiron","year":"2011","journal-title":"Eval - Diagn - Traitement"},{"issue":"2","key":"10.1016\/j.bpa.2023.02.003_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1213\/ANE.0000000000004425","article-title":"Intrathecal drug delivery systems for cancer pain: an analysis of a prospective, multicenter product surveillance registry","volume":"130","author":"Stearns","year":"2020","journal-title":"Anesth Analg"},{"issue":"12","key":"10.1016\/j.bpa.2023.02.003_bib35","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1526-4637.2011.01262.x","article-title":"Patient-controlled intrathecal analgesia for the management of breakthrough cancer pain: a retrospective review and commentary","volume":"12","author":"Brogan","year":"2011","journal-title":"Pain Med"},{"key":"10.1016\/j.bpa.2023.02.003_bib36","series-title":"Cochrane handbook for systematic reviews of interventions","article-title":"Choosing effect measures and computing estimates of effect","author":"Higgins","year":"2021"},{"issue":"7","key":"10.1016\/j.bpa.2023.02.003_bib37","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/ner.13161","article-title":"Evaluation of fixed intrathecal bupivacaine infusion doses in the oncologic population","volume":"23","author":"Chen","year":"2020","journal-title":"Neuromodulation"},{"issue":"9","key":"10.1016\/j.bpa.2023.02.003_bib38","first-page":"2323","article-title":"The association of presurgery psychological symptoms with postsurgery pain among cancer patients receiving implantable devices for pain management","volume":"22","author":"Aigner","year":"2014","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.bpa.2023.02.003_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000048379","article-title":"The significance of intrathecal opioid therapy for the treatment of neuropathic cancer pain conditions","volume":"75","author":"Becker","year":"2000","journal-title":"Stereotact Funct Neurosurg"},{"issue":"3","key":"10.1016\/j.bpa.2023.02.003_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.36076\/ppj.2013\/16\/251","article-title":"Infectious complications related to intrathecal drug delivery system and spinal cord stimulator system implantations at a comprehensive cancer pain center","volume":"16","author":"Engle","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.bpa.2023.02.003_bib41","first-page":"161","article-title":"Intrathecal morphine delivered by implanted manual pump for cancer pain","volume":"6","author":"Erdine","year":"1996","journal-title":"Pain Dig"},{"issue":"2","key":"10.1016\/j.bpa.2023.02.003_bib42","first-page":"200","article-title":"Long-term pain relief produced by intrathecal morphine infusion in 53 patients","volume":"72","author":"Onofrio","year":"1990","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.bpa.2023.02.003_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1525-1403.2009.00206.x","article-title":"Continuous morphine infusion: a retrospective study of efficacy, safety, and demographic variables","volume":"12","author":"Reig","year":"2009","journal-title":"Neuromodulation"},{"issue":"7","key":"10.1016\/j.bpa.2023.02.003_bib44","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ner.12759","article-title":"Retrospective analysis of intrathecal drug delivery: outcomes, efficacy, and risk for cancer-related pain at a high volume academic medical center","volume":"21","author":"Sayed","year":"2018","journal-title":"Neuromodulation"},{"issue":"3","key":"10.1016\/j.bpa.2023.02.003_bib45","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/pm\/pnw203","article-title":"Surgical site infections in cancer patients with intrathecal drug delivery devices","volume":"18","author":"Scanlon","year":"2017","journal-title":"Pain Med"},{"issue":"7","key":"10.1016\/j.bpa.2023.02.003_bib46","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/ner.13175","article-title":"Initiation of intrathecal drug delivery dramatically reduces systemic opioid use in patients with advanced cancer","volume":"23","author":"Sindt","year":"2020","journal-title":"Neuromodulation"},{"issue":"3","key":"10.1016\/j.bpa.2023.02.003_bib47","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1089\/jpm.2020.0206","article-title":"Evaluation of an intrathecal drug delivery protocol leads to rapid reduction of systemic opioids in the oncological population","volume":"24","author":"Spiegel","year":"2021","journal-title":"J Palliat Med"},{"key":"10.1016\/j.bpa.2023.02.003_bib48","first-page":"13","article-title":"Implanted drug delivery systems for spinal administration of morphine in cancer pain relief","volume":"11","author":"Yegul","year":"1999","journal-title":"Agri-Istanbul."},{"issue":"4","key":"10.1016\/j.bpa.2023.02.003_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1526-4637.2001.01052.x","article-title":"Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study","volume":"2","author":"Anderson","year":"2001","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.bpa.2023.02.003_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1526-4637.2006.00083.x","article-title":"Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study","volume":"7","author":"Du Pen","year":"2006","journal-title":"Pain Med"},{"issue":"11","key":"10.1016\/j.bpa.2023.02.003_bib51","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1097\/j.pain.0000000000001957","article-title":"Intrathecal delivery of hydromorphone vs morphine for refractory cancer pain: a multicenter, randomized, single-blind, controlled noninferiority trial","volume":"161","author":"Ma","year":"2020","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.bpa.2023.02.003_bib52","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/pm\/pnaa104","article-title":"Comparative effectiveness of targeted intrathecal drug delivery using a combination of bupivacaine with either low-dose fentanyl or hydromorphone in chronic back pain patients with lumbar postlaminectomy syndrome","volume":"21","author":"Ade","year":"2020","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.bpa.2023.02.003_bib53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.21037\/atm-20-3814","article-title":"Narrative review of intrathecal drug delivery (IDD): indications, devices and potential complications","volume":"9","author":"Capozza","year":"2021","journal-title":"Ann Transl Med"},{"issue":"3","key":"10.1016\/j.bpa.2023.02.003_bib54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1526-4637.2006.00155.x","article-title":"A\u00a0review of intrathecal fentanyl and sufentanil for the treatment of chronic pain","volume":"7","author":"Waara-Wolleat","year":"2006","journal-title":"Pain Med"},{"key":"10.1016\/j.bpa.2023.02.003_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/sni.sni_80_17","article-title":"Intrathecal catheter-associated inflammatory mass in a neurofibromatosis type-1 patient receiving fentanyl and bupivacaine","volume":"8","author":"Southwell","year":"2017","journal-title":"Surg Neurol Int"},{"issue":"3","key":"10.1016\/j.bpa.2023.02.003_bib56","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/ALN.0b013e3182a10fbf","article-title":"Intrathecal gabapentin to treat chronic intractable noncancer pain","volume":"119","author":"Rauck","year":"2013","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.bpa.2023.02.003_bib57","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0034-9356(09)70411-6","article-title":"[Spinal granuloma in a patient receiving a spinal infusion of morphine and clonidine]","volume":"56","author":"Abej\u00f3n","year":"2009","journal-title":"Rev Esp Anestesiol Reanim"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689623000083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689623000083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:22:47Z","timestamp":1776410567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689623000083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1521689623000083"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2023.02.003","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrathecal drug delivery in the management of chronic pain","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2023.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}